| Code | Description | Claims | Beneficiaries | Total Paid |
| 87481 |
|
23,920 |
6,217 |
$479K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
35,306 |
24,495 |
$450K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
36,299 |
28,599 |
$286K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
16,860 |
6,348 |
$269K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
35,149 |
24,353 |
$263K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
5,219 |
4,386 |
$251K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
24,205 |
18,215 |
$249K |
| 87482 |
|
15,403 |
8,895 |
$222K |
| 87512 |
|
17,790 |
10,568 |
$208K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
21,782 |
13,739 |
$135K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
547 |
507 |
$83K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,964 |
3,554 |
$76K |
| 87081 |
|
3,765 |
3,207 |
$75K |
| 88141 |
|
5,584 |
4,348 |
$68K |
| 87799 |
|
12,842 |
6,205 |
$67K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
5,647 |
5,472 |
$64K |
| 80053 |
Comprehensive metabolic panel |
32,359 |
20,077 |
$61K |
| 82805 |
|
4,138 |
1,204 |
$49K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
40,128 |
23,893 |
$46K |
| 87632 |
|
1,828 |
1,498 |
$33K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,719 |
5,513 |
$33K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
21,920 |
9,748 |
$28K |
| 87653 |
|
3,083 |
2,607 |
$26K |
| 88342 |
|
567 |
420 |
$20K |
| 82962 |
|
36,452 |
6,082 |
$20K |
| 86920 |
|
1,311 |
1,068 |
$19K |
| 87563 |
|
1,964 |
1,144 |
$19K |
| 87040 |
|
6,586 |
5,532 |
$17K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
5,779 |
5,462 |
$15K |
| 85027 |
|
16,579 |
8,403 |
$15K |
| 83735 |
|
12,962 |
6,010 |
$13K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
9,288 |
8,667 |
$12K |
| 81001 |
|
20,580 |
18,386 |
$10K |
| 84484 |
|
5,425 |
3,618 |
$10K |
| 86850 |
|
6,824 |
5,726 |
$8K |
| 88377 |
|
340 |
184 |
$8K |
| 81025 |
|
7,435 |
6,975 |
$7K |
| 87070 |
|
5,225 |
4,886 |
$7K |
| 86140 |
|
8,294 |
5,873 |
$7K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,561 |
1,447 |
$6K |
| 83690 |
|
6,165 |
5,285 |
$6K |
| 82803 |
|
1,089 |
576 |
$6K |
| 87631 |
|
286 |
281 |
$5K |
| 85730 |
|
6,050 |
4,460 |
$5K |
| 87077 |
|
2,658 |
2,363 |
$5K |
| 86900 |
|
9,212 |
7,917 |
$5K |
| 86901 |
|
9,532 |
8,212 |
$5K |
| 87186 |
|
2,129 |
1,936 |
$5K |
| 87529 |
|
515 |
321 |
$4K |
| 84702 |
|
1,169 |
1,005 |
$4K |
| 84100 |
|
5,448 |
1,979 |
$4K |
| 83605 |
|
2,406 |
1,553 |
$4K |
| 85610 |
|
6,955 |
5,212 |
$3K |
| 82247 |
|
3,767 |
1,881 |
$3K |
| 87511 |
|
380 |
327 |
$3K |
| 88307 |
|
39 |
38 |
$3K |
| 84703 |
|
2,565 |
2,405 |
$3K |
| 82550 |
|
2,607 |
2,059 |
$2K |
| 85046 |
|
2,803 |
1,372 |
$2K |
| 82248 |
|
3,114 |
1,851 |
$2K |
| 85007 |
|
4,539 |
2,115 |
$2K |
| 80074 |
|
52 |
52 |
$2K |
| 87430 |
|
640 |
614 |
$2K |
| 85384 |
|
1,585 |
1,124 |
$2K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
67 |
49 |
$2K |
| 84156 |
|
1,587 |
1,240 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
211 |
203 |
$2K |
| 87205 |
|
2,159 |
1,851 |
$1K |
| 88142 |
|
233 |
207 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,884 |
792 |
$1K |
| 80076 |
|
987 |
740 |
$1K |
| 84439 |
|
875 |
812 |
$1K |
| 80202 |
|
460 |
189 |
$1K |
| 82570 |
|
1,485 |
1,216 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
732 |
699 |
$1K |
| 87581 |
|
203 |
198 |
$1K |
| 83615 |
|
1,253 |
1,007 |
$915.64 |
| 86880 |
|
972 |
955 |
$903.55 |
| 80061 |
Lipid panel |
262 |
251 |
$889.97 |
| 85379 |
|
664 |
557 |
$840.10 |
| 87400 |
|
663 |
327 |
$836.44 |
| 82728 |
|
298 |
258 |
$810.93 |
| 87088 |
|
519 |
471 |
$784.12 |
| 84550 |
|
1,309 |
981 |
$724.26 |
| 85651 |
|
1,181 |
1,005 |
$713.93 |
| 80069 |
|
464 |
274 |
$702.12 |
| 87486 |
|
114 |
113 |
$663.66 |
| 86885 |
|
1,001 |
909 |
$622.90 |
| 82330 |
|
278 |
98 |
$575.83 |
| 82150 |
|
628 |
510 |
$551.12 |
| 86762 |
|
153 |
151 |
$516.65 |
| 86738 |
|
252 |
237 |
$490.31 |
| 86803 |
|
111 |
108 |
$412.46 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
62 |
45 |
$364.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
162 |
85 |
$338.73 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,701 |
1,586 |
$338.60 |
| 87150 |
|
98 |
89 |
$294.61 |
| 87340 |
|
237 |
213 |
$288.17 |
| 83880 |
|
736 |
567 |
$239.96 |
| 85014 |
|
667 |
412 |
$207.62 |
| 86592 |
|
340 |
325 |
$205.13 |
| 87625 |
|
37 |
13 |
$156.14 |
| 87210 |
|
201 |
191 |
$124.18 |
| 82731 |
|
13 |
12 |
$121.08 |
| 85018 |
|
300 |
220 |
$90.67 |
| 87640 |
|
25 |
13 |
$90.10 |
| 87420 |
|
31 |
31 |
$83.55 |
| 82010 |
|
100 |
72 |
$54.41 |
| 87076 |
|
15 |
12 |
$49.23 |
| 87116 |
|
16 |
12 |
$42.77 |
| 83550 |
|
29 |
28 |
$35.25 |
| 83540 |
|
45 |
42 |
$32.57 |
| 87075 |
|
24 |
24 |
$28.86 |
| 85362 |
|
31 |
28 |
$28.25 |
| 82784 |
|
12 |
12 |
$26.18 |
| 85008 |
|
58 |
48 |
$23.71 |
| 89051 |
|
27 |
19 |
$19.58 |
| 87045 |
|
12 |
12 |
$18.48 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
19 |
19 |
$15.14 |
| 82270 |
|
25 |
25 |
$10.88 |
| 84145 |
|
639 |
433 |
$0.00 |